DD244345A5 - Neue peptide - Google Patents

Neue peptide Download PDF

Info

Publication number
DD244345A5
DD244345A5 DD86287734A DD28773486A DD244345A5 DD 244345 A5 DD244345 A5 DD 244345A5 DD 86287734 A DD86287734 A DD 86287734A DD 28773486 A DD28773486 A DD 28773486A DD 244345 A5 DD244345 A5 DD 244345A5
Authority
DD
German Democratic Republic
Prior art keywords
lys
insulin
human insulin
arg
thr
Prior art date
Application number
DD86287734A
Other languages
German (de)
English (en)
Inventor
Jan Markussen
Original Assignee
����@��������@�a�k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ����@��������@�a�k�� filed Critical ����@��������@�a�k��
Publication of DD244345A5 publication Critical patent/DD244345A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DD86287734A 1985-03-12 1986-03-10 Neue peptide DD244345A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK113585A DK113585D0 (da) 1985-03-12 1985-03-12 Nye peptider

Publications (1)

Publication Number Publication Date
DD244345A5 true DD244345A5 (de) 1987-04-01

Family

ID=8101410

Family Applications (1)

Application Number Title Priority Date Filing Date
DD86287734A DD244345A5 (de) 1985-03-12 1986-03-10 Neue peptide

Country Status (22)

Country Link
EP (1) EP0194864B1 (xx)
JP (1) JPS61212598A (xx)
KR (1) KR930007433B1 (xx)
CN (1) CN86101489A (xx)
AT (1) ATE77391T1 (xx)
AU (1) AU612964B2 (xx)
CS (1) CS259536B2 (xx)
DD (1) DD244345A5 (xx)
DE (1) DE3685668T2 (xx)
DK (2) DK113585D0 (xx)
ES (1) ES8800276A1 (xx)
FI (1) FI861007A (xx)
GR (1) GR860687B (xx)
HU (1) HU201097B (xx)
IL (1) IL78103A0 (xx)
MY (1) MY102102A (xx)
NO (1) NO172441C (xx)
NZ (1) NZ215445A (xx)
PH (1) PH24260A (xx)
PT (1) PT82173B (xx)
YU (1) YU46001B (xx)
ZA (1) ZA861432B (xx)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK347086D0 (da) * 1986-07-21 1986-07-21 Novo Industri As Novel peptides
US5008241A (en) * 1985-03-12 1991-04-16 Novo Nordisk A/S Novel insulin peptides
DK119785D0 (da) * 1985-03-15 1985-03-15 Nordisk Gentofte Insulinpraeparat
DK437786D0 (da) * 1986-09-12 1986-09-12 Nordisk Gentofte Insulinprecursorer
EP0425482B1 (en) * 1988-07-20 1993-08-18 Novo Nordisk A/S Human insulin analogs and preparations containing them
DE3827533A1 (de) * 1988-08-13 1990-02-15 Hoechst Ag Pharmazeutische zubereitung zur behandlung des diabetes mellitus
DE3837825A1 (de) * 1988-11-08 1990-05-10 Hoechst Ag Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
DK134189D0 (da) * 1989-03-20 1989-03-20 Nordisk Gentofte Insulinforbindelser
US5130298A (en) * 1989-05-16 1992-07-14 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
DE3936876A1 (de) * 1989-11-06 1991-05-23 Hoechst Ag Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
AUPP609198A0 (en) * 1998-09-22 1998-10-15 Curtin University Of Technology Use of non-peptidyl compounds for the treatment of insulin related ailments
US6933272B1 (en) 1998-09-22 2005-08-23 Erik Helmerhorst Use of non-peptidyl compounds for the treatment of insulin related ailments
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
CA2552043A1 (en) 2004-01-21 2005-08-04 Novo Nordisk A/S Transglutaminase mediated conjugation of peptides
PT1969004E (pt) 2005-12-28 2011-11-25 Novo Nordisk As Composições que compreendem uma insulina acilada e zinco e método para criar tais composições
DE102006031962A1 (de) * 2006-07-11 2008-01-17 Sanofi-Aventis Deutschland Gmbh Amidiertes Insulin Glargin
DE102006031955A1 (de) * 2006-07-11 2008-01-17 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung von Insulinanaloga mit dibasischem B-Kettenende
NZ586589A (en) 2008-01-09 2012-04-27 Sanofi Aventis Deutschland Novel insulin analogues having an extremely delayed time-action profile
DE102008003566A1 (de) * 2008-01-09 2009-07-16 Sanofi-Aventis Deutschland Gmbh Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil
BRPI0907371A2 (pt) 2008-01-09 2015-11-24 Sanofi Aventis Deutschland derivados de insulina com um perfil de tempo-ação muito retardado
DK2349324T3 (en) 2008-10-17 2017-12-11 Sanofi Aventis Deutschland COMBINATION OF AN INSULIN AND A GLP-1 AGONIST
US20120241356A1 (en) * 2009-07-06 2012-09-27 Sanofi-Aventis Deutschland Gmbh Heat- and vibration-stable insulin preparations
KR101836070B1 (ko) 2009-11-13 2018-03-09 사노피-아벤티스 도이칠란트 게엠베하 Ｇｌｐ－１ 작용제, 인슐린 및 메티오닌을 포함하는 약제학적 조성물
JP5973918B2 (ja) 2009-11-13 2016-08-23 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Ｇｌｐ−１アゴニスト及びメチオニンを含む薬学的組成物
AU2011252127B2 (en) * 2010-05-10 2014-02-20 Novo Nordisk A/S Process for the preparation of insulin-zinc complexes
PT2611458T (pt) 2010-08-30 2016-12-16 Sanofi Aventis Deutschland Utilização de ave0010 para o fabrico de um medicamento para o tratamento da diabetes mellitus tipo 2
CN102174495A (zh) * 2011-01-20 2011-09-07 马忠仁 一种提取糜胰蛋白酶的方法
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
CN108079281A (zh) 2011-08-29 2018-05-29 赛诺菲-安万特德国有限公司 用于2型糖尿病患者中的血糖控制的药物组合
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
CN107206058A (zh) 2014-12-12 2017-09-26 赛诺菲-安万特德国有限公司 甘精胰岛素/利西拉来固定比率配制剂
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK319780A (da) * 1980-07-24 1982-01-25 Forenede Bryggerier As Fremgangsmaade til enzymatisk udskiftning af b-30 aminosyren i insuliner
DE3326472A1 (de) * 1983-07-22 1985-02-14 Hoechst Ag, 6230 Frankfurt Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
DE3333640A1 (de) * 1983-09-17 1985-04-25 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von insulin-derivaten, deren b-kette c-terminal verlaengert ist, neue basisch modifizierte insulin-derivate diese enthaltende mittel und ihre verwendung
DK119785D0 (da) * 1985-03-15 1985-03-15 Nordisk Gentofte Insulinpraeparat

Also Published As

Publication number Publication date
NO860920L (no) 1986-09-15
NZ215445A (en) 1989-07-27
PH24260A (en) 1990-05-04
KR860007288A (ko) 1986-10-10
HUT41052A (en) 1987-03-30
YU34586A (en) 1988-10-31
DK113585D0 (da) 1985-03-12
DK158677C (da) 1990-12-31
JPS61212598A (ja) 1986-09-20
DE3685668T2 (de) 1993-01-14
PT82173B (pt) 1988-07-29
CS259536B2 (en) 1988-10-14
PT82173A (en) 1986-04-01
IL78103A0 (en) 1986-07-31
ZA861432B (en) 1986-11-26
DE3685668D1 (en) 1992-07-23
EP0194864A2 (en) 1986-09-17
EP0194864B1 (en) 1992-06-17
CN86101489A (zh) 1987-01-21
DK158677B (da) 1990-07-02
AU612964B2 (en) 1991-07-25
CS166686A2 (en) 1987-12-17
KR930007433B1 (ko) 1993-08-10
MY102102A (en) 1992-03-31
ES552879A0 (es) 1987-11-01
FI861007A (fi) 1986-09-13
DK107086D0 (da) 1986-03-10
YU46001B (sh) 1992-12-21
NO172441B (no) 1993-04-13
AU5449586A (en) 1986-09-18
NO172441C (no) 1993-07-21
GR860687B (en) 1986-07-11
HU201097B (en) 1990-09-28
EP0194864A3 (en) 1989-01-11
DK107086A (da) 1986-11-07
ATE77391T1 (de) 1992-07-15
FI861007A0 (fi) 1986-03-11
ES8800276A1 (es) 1987-11-01

Similar Documents

Publication Publication Date Title
DE3685668T2 (de) Peptide.
DE3788684T2 (de) Peptide.
DE69722397T2 (de) Insulin-derivate und ihre verwendung
EP0132769B1 (de) Pharmazeutisches Mittel zur Behandlung des Diabetes mellitus
EP0885961B1 (de) Neue Insulinderivate mit schnellem Wirkungseintritt
DE3880346T2 (de) Insulinderivate.
EP0132770B1 (de) Neue Insulin-Derivate, Verfahren zu deren Herstellung und deren Verwendung sowie pharmazeutische Mittel zur Behandlung des Diabetes mellitus
DE69631996T2 (de) Verfahren zur Herstellung von acylierten Proteinpuder
DE69632224T2 (de) Reduzierung von Gelation von Fettsäureacylierten Proteinen unter Nutzung von Zitratpuffer
DE69529708T2 (de) Herstellung von stabilen Zink-Insulinanalogen-Kristallen
EP2229407B1 (de) Neue insulinderivate mit extrem verzögertem zeit- / wirkungsprofil
AT408611B (de) Insulinanalogon-protamin-komplex
DE69629210T2 (de) Insulinabkömmlinge
EP0368187B1 (de) Neue Insulinderivate, ihre Verwendung und eine sie enthaltende pharmazeutische Zubereitung
DE69816409T2 (de) Kristallines Parathyroidhormon
DE3687500T2 (de) Insulinabkoemmlinge und arzneimittel die diese enthalten.
EP0821006B1 (de) Insulinderivate mit erhöhter Zinkbindung
DE2600971A1 (de) Therapeutisches insulinpraeparat sowie verfahren zur herstellung eines stabilen insulinpraeparats mit dauerwirkung.
DE102008003566A1 (de) Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil
EP1161452A2 (de) Kovalent verbrückte insulindimere
DE3587227T2 (de) Antidiabetikaverbindungen.
EP1084248A2 (de) Neue insulinanaloga mit erhöhter zinkbindung
DE3587226T2 (de) Antidiabetikaverbindungen.
EP0622376B1 (de) Amorphe monosphärische Formen von Insulinderivaten
EP0137361B1 (de) In Position B 30 modifizierte Insulin-Derivate, Verfahren zu deren Herstellung und deren Verwendung sowie pharmazeutische Mittel zur Behandlung des Diabetes mellitus

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee